Balance and stealth: The role of noncoding RNAs in the regulation of virus gene expression

Annual Review of Virology

Volumn 1, Issue 1, 2014, Pages 89-109

  Cox, Jennifer E ^a   Sullivan, Christopher S ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

Autoregulation; Latency; MicroRNAs; Persistence; Reactivation; Stress

Indexed keywords

ANTIVIRUS AGENT; DOUBLE STRANDED DNA; MICRORNA; MICRORNA 122; NUCLEAR RNA; UNTRANSLATED RNA;

3' UNTRANSLATED REGION; ARTICLE; BOVINE HERPESVIRUS 1; CELL STRESS; CELL VIABILITY; CLINICAL TRIAL (TOPIC); EPSTEIN BARR VIRUS; GENE EXPRESSION REGULATION; GENE TARGETING; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HERPESVIRIDAE; HOST RESISTANCE; HUMAN; HUMAN CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS; INFECTIOUS LARYNGOTRACHEITIS VIRUS; LATENT VIRUS INFECTION; MAREK'S DISEASE VIRUS 1; NONHUMAN; POLYOMAVIRUS; PRIORITY JOURNAL; RETROVIRIDAE; VIRUS; VIRUS CELL INTERACTION; VIRUS GENE; VIRUS GENOME; VIRUS RECOMBINANT; VIRUS REPLICATION; VIRUS STRAIN;

METAZOA;

EID: 85017008561     PISSN: 2327056X     EISSN: 23270578     Source Type: Journal    
DOI: 10.1146/annurev-virology-031413-085439     Document Type: Article

References (172)

1. Lee RC, Feinbaum RL, Ambros V. 1993. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75:843-54
2. Ulitsky I, Bartel DP. 2013. lincRNAs: genomics, evolution, and mechanisms. Cell 154:26-46
3. Wang KC, Chang HY. 2011. Molecular mechanisms of long noncoding RNAs. Mol. Cell 43:904-14
4. Baltimore D. 1971. Expression of animal virus genomes. Bacteriol. Rev. 35:235-41
5. Funk A, TruongK,NagasakiT,Torres S, FlodenN, et al. 2010.RNA structures required for production of subgenomic flavivirus RNA. J. Virol. 84:11407-17
6. Grundhoff A, Sullivan CS. 2011. Virus-encoded microRNAs. Virology 411:325-43
7. Kincaid RP, Burke JM, Cox JC, de Villiers EM, Sullivan CS. 2013. A human torque teno virus encodes a microRNA that inhibits interferon signaling. PLoS Pathog. 9:e1003818
8. Kincaid RP, Burke JM, Sullivan CS. 2012. RNA virus microRNA that mimics a B-cell oncomiR. Proc. Natl. Acad. Sci. USA 109:3077-82
9. Yao Y, Smith LP,Nair V, Watson M. 2014. An avian retrovirus uses canonical expression and processing mechanisms to generate viral microRNA. J. Virol. 88:2-9
10. Kincaid RP, Sullivan CS. 2012. Virus-encoded microRNAs: an overview and a look to the future. PLoS Pathog. 8:e1003018
11. Sullivan CS. 2008. New roles for large and small viral RNAs in evading host defences. Nat. Rev. Genet. 9:503-7
12. Umbach JL,Cullen BR. 2009. The role of RNAi and microRNAs in animal virus replication and antiviral immunity. Genes Dev. 23:1151-64
13. Boss IW, Renne R. 2010. Viral miRNAs: tools for immune evasion. Curr. Opin. Microbiol. 13:540-45
14. Sullivan CS, Cullen BR. 2009. Non-coding regulatory RNAs of the DNA tumor viruses. In DNA Tumor Viruses, ed. B Damania, JM Pipas, pp. 645-82. New York: Springer
15. Sedger LM. 2013. MicroRNA control of interferons and interferon induced anti-viral activity. Mol. Immunol. 56:781-93
16. Subramanian S, Steer CJ. 2010. MicroRNAs as gatekeepers of apoptosis. J. Cell. Physiol. 223:289-98
17. Chen CZ, Schaffert S, Fragoso R, Loh C. 2013. Regulation of immune responses and tolerance: the microRNA perspective. Immunol. Rev. 253:112-28
18. Farazi TA, Hoell JI, Morozov P, Tuschl T. 2013. MicroRNAs in human cancer. Adv. Exp. Med. Biol. 774:1-20
19. Cullen BR. 2004. Transcription and processing of human microRNA precursors. Mol. Cell 16:861-65
20. Flynt AS, Lai EC. 2008. Biological principles of microRNA-mediated regulation: shared themes amid diversity. Nat. Rev. Genet. 9:831-42
21. Zisoulis DG, Lovci MT, Wilbert ML, Hutt KR, Liang TY, et al. 2010. Comprehensive discovery of endogenous Argonaute binding sites in Caenorhabditis elegans. Nat. Struct. Mol. Biol. 17:173-79
22. Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, et al. 2005. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 433:769-73
23. Seo GJ, Chen CJ, Sullivan CS. 2009. Merkel cell polyomavirus encodes a microRNA with the ability to autoregulate viral gene expression. Virology 383:183-87
24. Seo GJ, Fink LHL, O'Hara B, Atwood WJ, Sullivan CS. 2008. Evolutionarily conserved function of a viral microRNA. J. Virol. 82:9823-28
25. Sullivan CS, Grundhoff AT, Tevethia S, Pipas JM, Ganem D. 2005. SV40-encoded microRNAs regulate viral gene expression and reduce susceptibility to cytotoxic T cells. Nature 435:682-86
26. Barth S, Pfuhl T, Mamiani A, Ehses C, Roemer K, et al. 2008. Epstein-Barr virus-encoded microRNA miR-BART2 down-regulates the viral DNA polymerase BALF5. Nucleic Acids Res. 36:666-75
27. Sullivan CS, Sung CK, Pack CD, Grundhoff A, Lukacher AE, et al. 2009. Murine polyomavirus encodes a microRNA that cleaves early RNA transcripts but is not essential for experimental infection. Virology 387:157-67
28. Bhattacharyya SN, Habermacher R, Martine U, Closs EI, Filipowicz W. 2006. Stress-induced reversal of microRNA repression and mRNA P-body localization in human cells. Cold Spring Harb. Symp. Quant. Biol. 71:513-21
29. Leung AKL, Vyas S, Rood JE, Bhutkar A, Sharp PA, Chang P. 2011. Poly(ADP-ribose) regulates stress responses and microRNA activity in the cytoplasm. Mol. Cell 42:489-99
30. Seo GJ, Kincaid RP, Phanaksri T, Burke JM, Pare JM, et al. 2013. Reciprocal inhibition between intracellular antiviral signaling and the RNAi machinery in mammalian cells. Cell Host Microbe 14:435-45
31. Bhattacharyya SN, Habermacher R, Martine U, Closs EI, Filipowicz W. 2006. Relief of microRNAmediated translational repression in human cells subjected to stress. Cell 125:1111-24
32. Vasudevan S, Tong Y, Steitz JA. 2007. Switching from repression to activation: microRNAs can upregulate translation. Science 318:1931-34
33. Vasudevan S, Steitz JA. 2007. AU-rich-element-mediated upregulation of translation by FXR1 and Argonaute 2. Cell 128:1105-18
34. Ebert MS, Sharp PA. 2012. Roles for microRNAs in conferring robustness to biological processes. Cell 149:515-24
35. Cassidy JJ, Jha AR, Posadas DM, Giri R, Venken KJT, et al. 2013. miR-9a minimizes the phenotypic impact of genomic diversity by buffering a transcription factor. Cell 155:1556-67
36. Mendell JT, Olson EN. 2012. MicroRNAs in stress signaling and human disease. Cell 148:1172-87
37. Peláez N, Carthew RW. 2012. Biological robustness and the role of microRNAs: a network perspective. Curr. Top. Dev. Biol. 99:237-55
38. Kozomara A, Griffiths-Jones S. 2011. miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res. 39:D152-57
39. Grey F, Meyers H, White EA, Spector DH, Nelson J. 2007. A human cytomegalovirus-encoded microRNA regulates expression of multiple viral genes involved in replication. PLoS Pathog. 3:e163
40. Murphy E, Vanícek J, Robins H, Shenk T, Levine AJ. 2008. Suppression of immediate-early viral gene expression by herpesvirus-codedmicroRNAs: implications for latency. Proc. Natl. Acad. Sci. USA 105:5453-58
41. Forte E, Luftig MA. 2011. The role of microRNAs in Epstein-Barr virus latency and lytic reactivation. Microbes Infect. 13:1156-67
42. Lieberman PM. 2013. Keeping it quiet: chromatin control of gammaherpesvirus latency. Nat. Rev. Microbiol. 11:863-75
43. Wilson AC, Mohr I. 2012. A cultured affair: HSV latency and reactivation in neurons. Trends Microbiol. 20:604-11
44. Umbach JL, Kramer MF, Jurak I, Karnowski HW, Coen DM, Cullen BR. 2008. MicroRNAs expressed by herpes simplex virus 1 during latent infection regulate viral mRNAs. Nature 454:780-83
45. Jurak I, Griffiths A, Coen DM. 2011. Mammalian alphaherpesvirus miRNAs. Biochim. Biophys. Acta 1809:641-53
46. Boutell C, Everett RD. 2013. Regulation of alphaherpesvirus infections by the ICP0 family of proteins. J. Gen. Virol. 94:465-81
47. Everett RD. 2000. ICP0, a regulator of herpes simplex virus during lytic and latent infection. BioEssays 22:761-70
48. Everett RD, Parsy ML, Orr A. 2009. Analysis of the functions of herpes simplex virus type 1 regulatory protein ICP0 that are critical for lytic infection and derepression of quiescent viral genomes. J. Virol. 83:4963-77
49. SmithMC, Boutell C, Davido DJ. 2011. HSV-1 ICP0: paving the way for viral replication. Future Virol. 6:421-29
50. Flores O, Nakayama S, Whisnant AW, Javanbakht H, Cullen BR, Bloom DC. 2013. Mutational inactivation of herpes simplex virus 1 microRNAs identifies viral mRNA targets and reveals phenotypic effects in culture. J. Virol. 87:6589-603
51. Dölken L, Pfeffer S, Koszinowski UH. 2009. Cytomegalovirus microRNAs. Virus Genes 38:355-64
52. Huang Y, Qi Y, Ma Y, He R, Ji Y, et al. 2013. Down-regulation of human cytomegalovirus UL138, a novel latency-associated determinant, by hcmv-miR-UL36. J. Biosci. 38:479-85
53. Hancock MH, Tirabassi RS, Nelson JA. 2012. Rhesus cytomegalovirus encodes seventeen microRNAs that are differentially expressed in vitro and in vivo. Virology 425:133-42
54. Stern-Ginossar N, Saleh N, Goldberg MD, Prichard M, Wolf DG, Mandelboim O. 2009. Analysis of human cytomegalovirus-encoded microRNA activity during infection. J. Virol. 83:10684-93
55. Fu M, Gao Y, Zhou Q, Zhang Q, Peng Y, et al. 2014. Human cytomegalovirus latent infection alters the expression of cellular and viral microRNA. Gene 536:272-78
56. Dölken L, Krmpotic A, Kothe S, Tuddenham L, Tanguy M, et al. 2010. Cytomegalovirus microRNAs facilitate persistent virus infection in salivary glands. PLoS Pathog. 6:e1001150
57. Gottwein E,CorcoranDL, MukherjeeN, Skalsky RL,HafnerM, et al. 2011. Viral microRNA targetome of KSHV-infected primary effusion lymphoma cell lines. Cell Host Microbe 10:515-26
58. Grundhoff A, Sullivan CS, Ganem D. 2006. A combined computational and microarray-based approach identifies novel microRNAs encoded by human gamma-herpesviruses. RNA 12:733-50
59. Haecker I, Gay LA, Yang Y, Hu J, Morse AM, et al. 2012. Ago HITS-CLIP expands understanding of Kaposi's sarcoma-associated herpesvirus miRNA function in primary effusion lymphomas. PLoS Pathog. 8:e1002884
60. Pfeffer S, Sewer A, Lagos-Quintana M, Sheridan R, Sander C, et al. 2005. Identification of microRNAs of the herpesvirus family. Nat. Methods 2:269-76
61. Zhu Y, Haecker I, Yang Y, Gao SJ, Renne R. 2013. γ-Herpesvirus-encoded miRNAs and their roles in viral biology and pathogenesis. Curr. Opin. Virol. 3:266-75
62. Lukac DM, Kirshner JR, Ganem D. 1999. Transcriptional activation by the product of open reading frame 50 of Kaposi's sarcoma-associated herpesvirus is required for lytic viral reactivation in B cells. J. Virol. 73:9348-61
63. Lin X, Liang D, He Z, Deng Q, Robertson ES, Lan K. 2011. miR-K12-7-5p encoded by Kaposi's sarcoma-associated herpesvirus stabilizes the latent state by targeting viral ORF50/RTA. PLoS ONE 6:e16224
64. Lu F, StedmanW, Yousef M, Renne R, Lieberman PM. 2010. Epigenetic regulation of Kaposi's sarcoma-associated herpesvirus latency by virus-encoded microRNAs that target Rta and the cellular Rbl2-DNMT pathway. J. Virol. 84:2697-706
65. Lei X, Bai Z, Ye F, Xie J, Kim CG, et al. 2010. Regulation of NF-κB inhibitor IκBα and viral replication by a KSHV microRNA. Nat. Cell Biol. 12:193-99
66. Liang D, Gao Y, Lin X, He Z, Zhao Q, et al. 2011. A human herpesvirus miRNA attenuates interferon signaling and contributes to maintenance of viral latency by targeting IKKε. Cell Res. 21:793-806
67. Lu CC, Li Z, Chu CY, Feng J, Feng J, et al. 2010. MicroRNAs encoded by Kaposi's sarcoma-associated herpesvirus regulate viral life cycle. EMBO Rep. 11:784-90
68. Moody R, Zhu Y, Huang Y, Cui X, Jones T, et al. 2013. KSHV microRNAs mediate cellular transformation and tumorigenesis by redundantly targeting cell growth and survival pathways. PLoS Pathog. 9:e1003857
69. Ziegelbauer JM, Sullivan CS, Ganem D. 2009. Tandem array-based expression screens identify host mRNA targets of virus-encoded microRNAs. Nat. Genet. 41:130-34
70. Umbach JL, Strelow LI, Wong SW, Cullen BR. 2010. Analysis of rhesus rhadinovirus microRNAs expressed in virus-induced tumors from infected rhesus macaques. Virology 405:592-99
71. Bruce AG, Ryan JT, Thomas MJ, Peng X, Grundhoff A, et al. 2013. Next-generation sequence analysis of the genome of RFHVMn, the macaque homolog of Kaposi's sarcoma (KS)-associated herpesvirus, from a KS-like tumor of a pig-tailed macaque. J. Virol. 87:13676-93
72. Bai Z, Huang Y, Li W, Zhu Y, Jung JU, et al. 2014. Genomewide mapping and screening of Kaposi's sarcoma-associated herpesvirus (KSHV) 3' untranslated regions identify bicistronic and polycistronic viral transcripts as frequent targets of KSHV microRNAs. J. Virol. 88:377-92
73. McClure LV, Kincaid RP, Burke JM, Grundhoff A, Sullivan CS. 2013. Comprehensive mapping and analysis of Kaposi's sarcoma-associated herpesvirus 3' UTRs identify differential posttranscriptional control of gene expression in lytic versus latent infection. J. Virol. 87:12838-49
74. Lin YT, Sullivan CS. 2011. Expanding the role of Drosha to the regulation of viral gene expression. Proc. Natl. Acad. Sci. USA 108:11229-34
75. Cai X, Schäfer A, Lu S, Bilello JP, Desrosiers RC, et al. 2006. Epstein-Barr virus microRNAs are evolutionarily conserved and differentially expressed. PLoS Pathog. 2:e23
76. Pfeffer S, ZavolanM, Grässer FA, ChienM, Russo JJ, et al. 2004. Identification of virus-encoded microRNAs. Science 304:734-36
77. Riley KJ, Rabinowitz GS, Yario TA, Luna JM, Darnell RB, Steitz JA. 2012. EBV and humanmicroRNAs co-target oncogenic and apoptotic viral and human genes during latency. EMBO J. 31:2207-21
78. Iizasa H, Wulff BE, Alla NR, Maragkakis M, Megraw M, et al. 2010. Editing of Epstein-Barr virus-encoded BART6 microRNAs controls their Dicer targeting and consequently affects viral latency. J. Biol. Chem. 285:33358-70
79. Seto E, Moosmann A, Grömminger S, Walz N, Grundhoff A, Hammerschmidt W. 2010. Micro RNAs of Epstein-Barr virus promote cell cycle progression and prevent apoptosis of primary human B cells. PLoS Pathog. 6:e1001063
80. DeCaprio JA, Garcea RL. 2013. A cornucopia of human polyomaviruses. Nat. Rev. Microbiol. 11:264-76
81. Korup S, Rietscher J, Calvignac-Spencer S, Trusch F, Hofmann J, et al. 2013. Identification of a novel human polyomavirus in organs of the gastrointestinal tract. PLoS ONE 8:e58021
82. Delbue S, Ferraresso M, Ghio L, Carloni C, Carluccio S, et al. 2013. A review on JC virus infection in kidney transplant recipients. Clin. Dev. Immunol. 2013:926391
83. Hirsch HH, Kardas P, Kranz D, Leboeuf C. 2013. The human JC polyomavirus ( JCPyV): virological background and clinical implications. APMIS 121:685-727
84. Rinaldo CH, Tylden GD, Sharma BN. 2013. The human polyomavirus BK (BKPyV): virological background and clinical implications. APMIS 121:728-45
85. Kazem S, van der Meijden E, Feltkamp MCW. 2013. The trichodysplasia spinulosa-associated polyomavirus: virological background and clinical implications. APMIS 121:770-82
86. Cole CN. 1996. Polyomaviridae: the viruses and their replication. In Fields Virology, ed.DMKnipe, PM Howley, pp. 1997-2043. Philadelphia: Lippincott-Raven. 3rd ed.
87. Cantalupo P, Doering A, Sullivan CS, Pal A, Peden KWC, et al. 2005. Complete nucleotide sequence of polyomavirus SA12. J. Virol. 79:13094-104
88. Chen CJ, Cox JE, Kincaid RP, Martinez A, Sullivan CS. 2013. Divergent microRNA targetomes of closely related circulating strains of a polyomavirus. J. Virol. 87:11135-47
89. Chen CJ, Kincaid RP, Seo GJ, Bennett MD, Sullivan CS. 2011. Insights into Polyomaviridae microRNA function derived from study of the bandicoot papillomatosis carcinomatosis viruses. J. Virol. 85:4487-500
90. Broekema NM, Imperiale MJ. 2013. miRNA regulation of BK polyomavirus replication during early infection. Proc. Natl. Acad. Sci. USA 110:8200-5
91. Zhang S, Sroller V, Zanwar P, Chen CJ, Halvorson SJ, et al. 2014. Viral microRNA effects on pathogenesis of polyomavirus SV40 infections in Syrian golden hamsters. PLoS Pathogens 10:e1003912
92. Goff SP. 2001. Retroviridae: the retroviruses and their replication. In Fields Virology, ed. DM Knipe, PM Howley, DE Griffin, RA Lamb, MA Martin, B Roizman, pp. 1871-922. Philadelphia: Lippincott Williams & Wilkins. 4th ed.
93. Lin J, Cullen BR. 2007. Analysis of the interaction of primate retroviruses with the human RNA interference machinery. J. Virol. 81:12218-26
94. Schmidt M, Herchenröder O, Heeney J, Rethwilm A. 1997. Long terminal repeat U3 length polymorphism of human foamy virus. Virology 230:167-78
95. Rethwilm A, Baunach G, Netzer KO,Maurer B, Borisch B, terMeulen V. 1990. Infectious DNA of the human spumaretrovirus. Nucleic Acids Res. 18:733-38
96. Neves M, Périès J, Säib A. 1998. Study of human foamy virus proviral integration in chronically infected murine cells. Res. Virol. 149:393-401
97. Gregory SM, West JA, Dillon PJ, Hilscher C, Dittmer DP,Damania B. 2009. Toll-like receptor signaling controls reactivation of KSHV from latency. Proc. Natl. Acad. Sci. USA 106:11725-30
98. Li X, Feng J, Sun R. 2011. Oxidative stress induces reactivation of Kaposi's sarcoma-associated herpesvirus and death of primary effusion lymphoma cells. J. Virol. 85:715-24
99. Lu C, Zeng Y, Huang Z, Huang L, Qian C, et al. 2005. Human herpesvirus 6 activates lytic cycle replication of Kaposi's sarcoma-associated herpesvirus. Am. J. Pathol. 166:173-83
100. Palmisano I, Della Chiara G, D'Ambrosio RL, Huichalaf C, Brambilla P, et al. 2012. Amino acid starvation induces reactivation of silenced transgenes and latentHIV-1 provirus via down-regulation of histone deacetylase 4 (HDAC4). Proc. Natl. Acad. Sci. USA 109:E2284-93
101. Qin D, Zeng Y, Qian C, Huang Z, Lv Z, et al. 2008. Induction of lytic cycle replication of Kaposi's sarcoma-associated herpesvirus by herpes simplex virus type 1: involvement of IL-10 and IL-4. Cell Microbiol. 10:713-28
102. Taylor GM, Raghuwanshi SK, Rowe DT, Wadowsky RM, Rosendorff A. 2011. Endoplasmic reticulum stress causes EBV lytic replication. Blood 118:5528-39
103. Vieira J, O'Hearn P, Kimball L, Chandran B, Corey L. 2001. Activation of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) lytic replication by human cytomegalovirus. J. Virol. 75:1378-86
104. Cai X, Li G, Laimins LA, Cullen BR. 2006. Human papillomavirus genotype 31 does not express detectable microRNA levels during latent or productive virus replication. J. Virol. 80:10890-93
105. Gunasekharan V, Laimins LA. 2013. Human papillomaviruses modulate microRNA 145 expression to directly control genome amplification. J. Virol. 87:6037-43
106. Crow JM. 2012. HPV: the global burden. Nature 488:S2-3
107. Gu W, An J, Ye P, Zhao KN, Antonsson A. 2011. Prediction of conserved microRNAs from skin and mucosal human papillomaviruses. Arch. Virol. 156:1161-71
108. Qian K, Pietilä T, Rönty M, Michon F, FrilanderMJ, et al. 2013. Identification and validation of human papillomavirus encoded microRNAs. PLoS ONE 8:e70202
109. Doorbar J. 2005. The papillomavirus life cycle. J. Clin. Virol. 32(Suppl. 1):S7-15
110. Zacks MA, Paessler S. 2010. Encephalitic alphaviruses. Vet. Microbiol. 140:281-86
111. Weaver SC. 2005. Host range, amplification and arboviral disease emergence. In Infectious Diseases from Nature: Mechanisms of Viral Emergence and Persistence, ed. CJ Peters, CH Calisher, pp. 33-44. Vienna: Springer
112. Trobaugh DW, Gardner CL, Sun C, Haddow AD, Wang E, et al. 2013. RNA viruses can hijack vertebrate microRNAs to suppress innate immunity. Nature 506:245-48
113. Whisnant AW, Bogerd HP, Flores O, Ho P, Powers JG, et al. 2013. In-depth analysis of the interaction of HIV-1 with cellular microRNA biogenesis and effector mechanisms. mBio 4:e000193
114. Klase Z, Kale P, Winograd R, Gupta MV, Heydarian M, et al. 2007. HIV-1 TAR element is processed by Dicer to yield a viral micro-RNA involved in chromatin remodeling of the viral LTR. BMCMol. Biol. 8:63
115. Omoto S, Ito M, Tsutsumi Y, Ichikawa Y, Okuyama H, et al. 2004. HIV-1 nef suppression by virally encoded microRNA. Retrovirology 1:44
116. Schopman NCT, Willemsen M, Liu YP, Bradley T, van Kampen A, et al. 2012. Deep sequencing of virus-infected cells reveals HIV-encoded small RNAs. Nucleic Acids Res. 40:414-27
117. Ahluwalia JK, Khan SZ, Soni K, Rawat P, Gupta A, et al. 2008. Human cellular microRNA hsa-miR-29a interferes with viral nef protein expression and HIV-1 replication. Retrovirology 5:117
118. Huang J, Wang F, Argyris E, Chen K, Liang Z, et al. 2007. Cellular microRNAs contribute to HIV-1 latency in resting primary CD4+ T lymphocytes. Nat. Med. 13:1241-47
119. Zhang Q, Chen CY, Yedavalli VSRK, Jeang KT. 2013. NEAT1 long noncoding RNA and paraspeckle bodies modulate HIV-1 posttranscriptional expression. mBio 4:e00596-12
120. Skalsky RL, Cullen BR. 2010. Viruses, microRNAs, and host interactions. Annu. Rev. Microbiol. 64:123-41
121. Huang T, Zhang X. 2012. Functional analysis of a crustacean microRNA in host-virus interactions. J. Virol. 86:12997-3004
122. Kelly EJ, Nace R, Barber GN, Russell SJ. 2010. Attenuation of vesicular stomatitis virus encephalitis through microRNA targeting. J. Virol. 84:1550-62
123. Pedersen IM, Cheng G, Wieland S, Volinia S, Croce CM, et al. 2007. Interferon modulation of cellular microRNAs as an antiviral mechanism. Nature 449:919-22
124. Cullen BR. 2013. How do viruses avoid inhibition by endogenous cellular microRNAs? PLoS Pathog. 9:e1003694
125. Sarasin-Filipowicz M, Krol J, Markiewicz I, Heim MH, Filipowicz W. 2009. Decreased levels of microRNA miR-122 in individuals with hepatitis C responding poorly to interferon therapy. Nat. Med. 15:31-33
126. Berezikov E. 2011. Evolution ofmicroRNA diversity and regulation in animals. Nat. Rev. Genet. 12:846-60
127. Skalsky RL, Kang D, Linnstaedt SD, Cullen BR. 2014. Evolutionary conservation of primate lymphocryptovirus microRNA targets. J. Virol. 88:1617-35
128. Lecellier C-H, Dunoyer P, Arar K, Lehmann-Che J, Eyquem S, et al. 2005. A cellular microRNA mediates antiviral defense in human cells. Science 308:557-60
129. Kamel W, Segerman B, Öberg D, Punga T, Akusjärvi G. 2013. The adenovirus VA RNA-derived miRNAs are not essential for lytic virus growth in tissue culture cells. Nucleic Acids Res. 41:4802-12
130. Ma Y, Mathews MB. 1996. Structure, function, and evolution of adenovirus-associated RNA: a phylogenetic approach. J. Virol. 70:5083-99
131. Maran A,Mathews MB. 1988. Characterization of the double-stranded RNA implicated in the inhibition of protein synthesis in cells infected with amutant adenovirus defective forVARNA. Virology 164:106-13
132. Furuse Y, Ornelles DA, Cullen BR. 2013. Persistently adenovirus-infected lymphoid cells expressmicro-RNAs derived from the viral VAI and especially VAII RNA. Virology 447:140-45
133. Garnett CT, Erdman D, Xu W, Gooding LR. 2002. Prevalence and quantitation of species C adenovirus DNA in human mucosal lymphocytes. J. Virol. 76:10608-16
134. Aparicio O, Razquin N, Zaratiegui M, Narvaiza I, Fortes P. 2006. Adenovirus virus-associated RNA is processed to functional interfering RNAs involved in virus production. J. Virol. 80:1376-84
135. SunR,Lin SF,Gradoville L, MillerG. 1996. Polyadenylylated nuclearRNAencoded byKaposi sarcoma-associated herpesvirus. Proc. Natl. Acad. Sci. USA 93:11883-88
136. Mitton-Fry RM, DeGregorio SJ,Wang J, Steitz TA, Steitz JA. 2010. Poly(A) tail recognition by a viral RNA element through assembly of a triple helix. Science 330:1244-47
137. Conrad NK, Mili S, Marshall EL, Shu MD, Steitz JA. 2006. Identification of a rapid mammalian deadenylation-dependent decay pathway and its inhibition by a viral RNA element. Mol. Cell 24:943-53
138. Borah S,DarricarrèreN,Darnell A, Myoung J, Steitz JA. 2011. A viral nuclear noncodingRNAbinds relocalized poly(A) binding protein and is required for lateKSHVgene expression. PLoS Pathog. 7:e1002300
139. Rossetto CC, Tarrant-Elorza M, Verma S, Purushothaman P, Pari GS. 2013. Regulation of viral and cellular gene expression by Kaposi's sarcoma-associated herpesvirus polyadenylated nuclear RNA. J. Virol. 87:5540-53
140. Rossetto CC, Pari G. 2012. KSHV PAN RNA associates with demethylases UTX and JMJD3 to activate lytic replication through a physical interaction with the virus genome. PLoS Pathog. 8:e1002680
141. Arias C, Weisburd B, Stern-GinossarN,Mercier A,Madrid AS, et al. 2014. KSHV 2.0: a comprehensive annotation of the Kaposi's sarcoma-associated herpesvirus genome using next-generation sequencing reveals novel genomic and functional features. PLoS Pathog. 10:e1003847
142. Haussecker D, Kay MA. 2010. miR-122 continues to blaze the trail for microRNA therapeutics. Mol. Ther. 18:240-42
143. Jopling CL, Yi M, Lancaster AM, Lemon SM, Sarnow P. 2005. Modulation of hepatitis C virus RNA abundance by a liver-specific microRNA. Science 309:1577-81
144. tenOever B. 2009. MicroManipulating viral-based therapeutics. Discov. Med. 8:51-54
145. IbrišimovićM,KneidingerD, LionT,Klein R. 2013. An adenoviral vector-based expression and delivery system for the inhibition of wild-type adenovirus replication by artificial microRNAs. Antiviral Res. 97:10-23
146. Ylösmäki E, Hakkarainen T, Hemminki A, Visakorpi T, Andino R, Saksela K. 2008. Generation of a conditionally replicating adenovirus based on targeted destruction of E1A mRNA by a cell type-specific microRNA. J. Virol. 82:11009-15
147. Langlois RA, Albrecht RA, Kimble B, Sutton T, Shapiro JS, et al. 2013. MicroRNA-based strategy to mitigate the risk of gain-of-function influenza studies. Nat. Biotechnol. 31:844-47
148. Gall A, Palser A. 2013. An elephantine viral problem. Nat. Rev. Microbiol. 11:512
149. Furuse Y, Dastjerdi A, Steinbach F, Cullen BR. 2014. Analysis of viral microRNA expression by elephant endotheliotropic herpesvirus 1. Virology 454-55:102-8
150. Ross N, Gandhi MK,Nourse JP. 2013. The Epstein-Barr virus microRNA BART11-5p targets the early B-cell transcription factor EBF1. Am. J. Blood Res. 3:210-24
151. Lung RW, Tong JH, Sung Y, Leung P, Ng DC, et al. 2009. Modulation of LMP2A expression by a newly identified Epstein-Barr virus-encoded microRNA miR-BART22. Neoplasia 11:1174-84
152. Tang S, Patel A, Krause PR. 2009. Novel less-abundant viral microRNAs encoded by herpes simplex virus 2 latency-associated transcript and their roles in regulating ICP34.5 and ICP0 mRNAs. J. Virol. 83:1433-42
153. Tang S, Bertke AS, Patel A, Wang K, Cohen JI, Krause PR. 2008. An acutely and latently expressed herpes simplex virus 2 viral microRNA inhibits expression of ICP34.5, a viral neurovirulence factor. Proc. Natl. Acad. Sci. USA 105:10931-36
154. Jaber T,Workman A, Jones C. 2010. Small noncoding RNAs encoded within the bovine herpesvirus 1 latency-related gene can reduce steady-state levels of infected cell protein 0 (bICP0). J. Virol. 84:6297-307
155. WaidnerLA, Burnside J, Anderson AS, Bernberg EL, German MA, et al. 2011.AmicroRNA of infectious laryngotracheitis virus can downregulate and direct cleavage of ICP4 mRNA. Virology 411:25-31
156. Muylkens B, Coupeau D, Dambrine G, Trapp S, Rasschaert D. 2010. Marek's disease virus microRNA designated Mdv1-pre-miR-M4 targets both cellular and viral genes. Arch. Virol. 155:1823-37
157. Strassheim S, Stik G, Rasschaert D, Laurent S. 2012. Mdv1-miR-M7-5p, located in the newly identified first intron of the latency-associated transcript of Marek's disease virus, targets the immediate-early genes ICP4 and ICP27. J. Gen. Virol. 93:1731-42
158. Singh CP, Singh J, Nagaraju J. 2012. A baculovirus-encoded microRNA (miRNA) suppresses its host miRNA biogenesis by regulating the Exportin-5 cofactor Ran. J. Virol. 86:7867-79
159. Hussain M, Taft RJ, Asgari S. 2008. An insect virus-encoded microRNA regulates viral replication. J. Virol. 82:9164-70
160. Wu YL,Wu CP, Liu CYY, Hsu PWC,Wu EC, Chao YC. 2011. A non-coding RNA of insect HzNV-1 virus establishes latent viral infection through microRNA. Sci. Rep. 1:60
161. He Y, Yang K, Zhang X. 2014. Viral microRNAs targeting virus genes promote virus infection in shrimp in vivo. J. Virol. 88:1104-12
162. Yanagawa-Matsuda A, Kitamura T, Higashino F, Yamano S, Totsuka Y, Shindoh M. 2012. E1A expression might be controlled by miR-214 in cells with low adenovirus productivity. Virus Res. 170:85-90
163. Sagan SM, Sarnow P, Wilson JA. 2013. Modulation of GB virus B RNA abundance by microRNA-122: dependence on and escape from microRNA-122 restriction. J. Virol. 87:7338-47
164. Zhang G, Li Y, Zheng S, Liu M, Li X, Tang H. 2010. Suppression of hepatitis B virus replication by microRNA-199a-3p and microRNA-210. Antiviral Res. 88:169-75
165. Yan Q, Li W, Tang Q, Yao S, Lv Z, et al. 2013. Cellular microRNAs 498 and 320d regulate herpes simplex virus 1 induction of Kaposi's sarcoma-associated herpesvirus lytic replication by targeting RTA. PLoS ONE 8:e55832
166. Ma YJ, Yang J, Fan XL, Zhao HB, Hu W, et al. 2012. Cellular microRNA let-7c inhibits M1 protein expression of the H1N1 influenza A virus in infected human lung epithelial cells. J. Cell. Mol. Med. 16:2539-46
167. Sun JZ, Wang J, Yuan D, Wang S, Li Z, et al. 2013. Cellular microRNA miR-181b inhibits replication of mink enteritis virus by repression of non-structural protein 1 translation. PLoS ONE 8:e81515
168. Wen B, Dai H, Yang Y, Zhuang Y, Sheng R. 2013. MicroRNA-23b inhibits enterovirus 71 replication through downregulation of EV71 VPL protein. Intervirology 56:195-200
169. Zheng Z, Ke X, Wang M, He S, Li Q, et al. 2013. Human microRNA hsa-miR-296-5p suppresses enterovirus 71 replication by targeting the viral genome. J. Virol. 87:5645-56
170. Wang L, Qin Y, Tong L,Wu S,Wang Q, et al. 2012. miR-342-5p suppresses coxsackievirus B3 biosynthesis by targeting the 2C-coding region. Antiviral Res. 93:270-79
171. Tong L, Lin L,Wu S,Guo Z, Wang T, et al. 2013. Mir-10a∗ up-regulates coxsackievirus B3 biosynthesis by targeting the 3D-coding sequence. Nucleic Acids Res. 41:3760-71
172. Sisk JM, Witwer KW, Tarwater PM, Clements JE. 2013. SIV replication is directly downregulated by four antiviral miRNAs. Retrovirology 10:95